Aspect Partners’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$797 Buy
156
+25
+19% +$136 ﹤0.01% 605
2026
Q2
$690 Buy
131
+115
+719% +$605 ﹤0.01% 610
2026
Q1
$67 Buy
+16
New +$77 ﹤0.01% 703

Other funds holding SRTA

Aspect Partners's SRTA Position: Q3 2026 in Review

Aspect Partners increased its Strata Critical Medical Inc (SRTA) stake by 19% in Q3 2026, buying an estimated $136 and bringing the position to 156 shares worth $797. The position accounts for ﹤0.01% of the portfolio, ranked #605.

Aspect Partners first reported a position in SRTA in Q1 2026 and has held it in 3 quarters since. 22 funds tracked by Wall St. Rank hold SRTA as of Q3 2026.

  • Aspect Partners held 156 shares of Strata Critical Medical Inc worth $797 as of Q3 2026.
  • Aspect Partners bought 25 Strata Critical Medical Inc shares in Q3 2026, an estimated $136.
  • Strata Critical Medical Inc made up ﹤0.01% of Aspect Partners's portfolio in Q3 2026, its #605 holding.
  • Aspect Partners first reported a position in Strata Critical Medical Inc in Q1 2026 and has held it in 3 quarters since.
  • 22 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q3 2026.

Based on Aspect Partners's 13F filing for Q3 2026, filed 20 Oct 2026.